Fuso Pharmaceutical Industries,Ltd.

Tokyo Stock Exchange 4538.T

Fuso Pharmaceutical Industries,Ltd. Market Capitalization on January 31, 2025: USD 134.02 M

Fuso Pharmaceutical Industries,Ltd. Market Capitalization is USD 134.02 M on January 31, 2025, a 5.41% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Fuso Pharmaceutical Industries,Ltd. 52-week high Market Capitalization is USD 152.01 M on November 05, 2024, which is 13.42% above the current Market Capitalization.
Fuso Pharmaceutical Industries,Ltd. 52-week low Market Capitalization is USD 113.96 M on August 05, 2024, which is -14.97% below the current Market Capitalization.
Fuso Pharmaceutical Industries,Ltd. average Market Capitalization for the last 52 weeks is USD 130.60 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Tokyo Stock Exchange: 4538.T

Fuso Pharmaceutical Industries,Ltd.

CEO	Mr. Mikio Toda
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	1-7-10, Doshomachi
Employees	1,370
Sector	Consumers Staples
Industries Cleaning Supplies Automotive Parts Composite Materials Hardware & Electronics Non-Alcoholic Beverages Personal Care Pharmaceuticals Plastics

Description

Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such as injectables and artificial kidney dialysates; and medical machinery and equipment. It also rents real estate properties. The company was founded in 1937 and is headquartered in Osaka, Japan.

Key trends

Past 5 years